Cargando…

Cystatin C and cardiovascular risk in HIV infected patients

Detalles Bibliográficos
Autores principales:	Falasca, Katia, Ucciferri, Claudio, Mancino, Paola, Vignale, Francesca, Vecchiet, Jacopo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316062/ http://dx.doi.org/10.1186/1742-4690-7-S1-P62

Ejemplares similares

Hypertension and microalbuminuria in HIV infected patients: beneficial effects of the treatment with telmisartan
por: Ucciferri, Claudio, et al.
Publicado: (2010)

Long term effect of switching to darunavir/ritonavir in HIV infected patients previously on protease inhibitor therapy
por: Ucciferri, Claudio, et al.
Publicado: (2016)

Long term effect of telmisartan in HIV-positive male patients with high blood pressure
por: Ucciferri, Claudio, et al.
Publicado: (2015)

Use of Hematopoietic Growth Factor in the Management of Hematological Side Effects Associated to Antiviral Treatment for Hcv Hepatitis
por: Mancino, Paola, et al.
Publicado: (2010)

The impact of homocysteine, B(12), and D vitamins levels on functional neurocognitive performance in HIV-positive subjects
por: Falasca, Katia, et al.
Publicado: (2019)

Pidotimod in Paucisymptomatic SARS-CoV2 Infected Patients
por: Ucciferri, Claudio, et al.
Publicado: (2020)

Role of monoclonal antibody drugs in the treatment of COVID-19
por: Ucciferri, Claudio, et al.
Publicado: (2020)

Are monoclonal antibodies effective in patients with severe obesity in SARS‐CoV‐2 infected?
por: Ucciferri, Claudio, et al.
Publicado: (2023)

Cardiac Toxicity Associated with HCV Direct Antiviral Agents
por: Ucciferri, Claudio, et al.
Publicado: (2018)

Improving BNT162b2 mRNA Vaccine Tolerability without Efficacy Loss by Pidotimod Supplementation
por: Ucciferri, Claudio, et al.
Publicado: (2022)

Effect of Probiotic Supplement on Cytokine Levels in HIV-Infected Individuals: A Preliminary Study
por: Falasca, Katia, et al.
Publicado: (2015)

Risk Factors Associated with Poor Outcome in Patients with Infective Endocarditis: An Italian Single-Center Experience
por: Ucciferri, Claudio, et al.
Publicado: (2022)

Predictive factors and prevalence of microalbuminuria in HIV-infected patients: a cross-sectional analysis
por: Falasca, Katia, et al.
Publicado: (2017)

Molnupiravir as an Early Treatment for COVID-19: A Real Life Study
por: Pontolillo, Michela, et al.
Publicado: (2022)

New Therapeutic Options in Mild Moderate COVID-19 Outpatients
por: Ucciferri, Claudio, et al.
Publicado: (2022)

Parameters associated with diagnosis of COVID‐19 in emergency department
por: Ucciferri, Claudio, et al.
Publicado: (2021)

Canakinumab in a subgroup of patients with COVID-19
por: Ucciferri, Claudio, et al.
Publicado: (2020)

Effects of Probiotic Mixture Supplementation on the Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine in People Living with HIV
por: Reale, Marcella, et al.
Publicado: (2021)

Atypical Sites of Lymphadenopathy after Anti-COVID-19 Vaccine: Ultrasound Features
por: Cocco, Giulio, et al.
Publicado: (2022)

Early detection of pleuro‐pulmonary tuberculosis by bedside lung ultrasound: A case report and review of literature
por: Cocco, Giulio, et al.
Publicado: (2022)

Cystatin C in the prognostic stratification of patients with an acute coronary syndrome
por: Lago, A Lopez, et al.
Publicado: (2007)

Efficacy of canakinumab in mild or severe COVID‐19 pneumonia
por: Katia, Falasca, et al.
Publicado: (2021)

The degree of natriuretic peptide system activation in stable and high risk CHF characterized by increased cystatin C is not reflected in cGMP activation
por: Schirger, John A, et al.
Publicado: (2009)

Is cystatin C reliable in the anesthetized pig? An experimental study with special reference to septic shock
por: Eriksson, M, et al.
Publicado: (2012)

Prevalence and predictors of malignancies in a polycentric cohort of HIV patients from Italy
por: Mazzotta, Elena, et al.
Publicado: (2014)

Antiretroviral treatment and expression of the mRNA levels for Pgp, MRP1, MRP4 and MRP5 in HIV antiretroviral naïve patients. Follow-up at 48 weeks
por: Falasca, Francesca, et al.
Publicado: (2010)

Air and surface measurements of SARS-CoV-2 inside a bus during normal operation
por: Di Carlo, Piero, et al.
Publicado: (2020)

Prevalence of cardiovascular risk factors in Spanish HIV-1-infected male inmates
por: Golf, JP, et al.
Publicado: (2010)

Low serum phosphate levels are related to increased cardiovascular risk in HIV-1 infected patients
por: Grima, P, et al.
Publicado: (2010)

Are serum cystatin-C-based estimates better than those derived from serum creatinine in critically ill patients?
por: Baptista, JP, et al.
Publicado: (2012)

Comparison of the value of plasma and urine cystatin-C and neutrophil gelatinase-associated lipocalin levels in prediction of acute kidney injury in sepsis
por: Gursel, G
Publicado: (2011)

Single point measurement of cystatin C has similar performance as serum creatinine for assessment of kidney function in critically ill patients
por: Houthoofd, J, et al.
Publicado: (2015)

The majority of patients in a Swedish university hospital intensive care unit have reduced glomerular filtration rate measured by Cystatin C
por: Lipcsey, M, et al.
Publicado: (2007)

Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids
por: D’Ardes, Damiano, et al.
Publicado: (2020)

High plasma levels of parathyroid hormone (PTH) are associated with an increased cardiovascular risk among HIV-infected subjects
por: Spagnuolo, V, et al.
Publicado: (2010)

Human immunodeficiency virus infection and cardiovascular risk
por: Zaharia-Kézdi, Erzsébet Iringó, et al.
Publicado: (2014)

Autoimmunity and cystatin SA 1 deficiency behind chronic mucocutaneous candidiasis in autoimmune polyendocrine syndrome
por: Lindh, Emma, et al.
Publicado: (2012)

Prevalence of hepatitis C virus infection among HIV-infected people in Casablanca
por: Badaoui, L, et al.
Publicado: (2014)

An evaluation of outcomes, interventions and behaviour modifications following a cardiovascular MRI in HIV infected patients
por: Aftab, N, et al.
Publicado: (2015)

C-reactive protein and procalcitonin in septic and HIV infection patients
por: Silva, JM, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_rcie3hpg4gdoc81f9pstofonqj